Correlation Between Neogen and Qiagen NV
Can any of the company-specific risk be diversified away by investing in both Neogen and Qiagen NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neogen and Qiagen NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neogen and Qiagen NV, you can compare the effects of market volatilities on Neogen and Qiagen NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neogen with a short position of Qiagen NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neogen and Qiagen NV.
Diversification Opportunities for Neogen and Qiagen NV
Poor diversification
The 3 months correlation between Neogen and Qiagen is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Neogen and Qiagen NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qiagen NV and Neogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neogen are associated (or correlated) with Qiagen NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qiagen NV has no effect on the direction of Neogen i.e., Neogen and Qiagen NV go up and down completely randomly.
Pair Corralation between Neogen and Qiagen NV
Given the investment horizon of 90 days Neogen is expected to generate 2.09 times more return on investment than Qiagen NV. However, Neogen is 2.09 times more volatile than Qiagen NV. It trades about 0.01 of its potential returns per unit of risk. Qiagen NV is currently generating about -0.02 per unit of risk. If you would invest 1,590 in Neogen on August 24, 2024 and sell it today you would lose (132.00) from holding Neogen or give up 8.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Neogen vs. Qiagen NV
Performance |
| Timeline |
| Neogen |
| Qiagen NV |
Neogen and Qiagen NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neogen and Qiagen NV
The main advantage of trading using opposite Neogen and Qiagen NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neogen position performs unexpectedly, Qiagen NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will offset losses from the drop in Qiagen NV's long position.| Neogen vs. IDEXX Laboratories | Neogen vs. Twist Bioscience Corp | Neogen vs. Guardant Health | Neogen vs. Agilent Technologies |
| Qiagen NV vs. Neogen | Qiagen NV vs. Aclaris Therapeutics | Qiagen NV vs. IQVIA Holdings | Qiagen NV vs. Medpace Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |